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Abstract
Introduction: Mesenchymal Stem Cells (MSCs) can be isolated 
from several body tissues, including dental tissues. As a result of 
being capable of differentiating into a variety of cell types, it can 
be presumed that stem cell therapy has an advantage compared to 
other tissue repair methods. Objective: The aim of this paper is 
to provide a review about current and future materials for scaffolds 
to carry stem cells in tissue engineering in Dentistry, especially for 
bone tissue repair. Literature review: MSCs have great therapeutic 
potential in tissue engineering, they can be expanded in vitro, and 
combined with scaffolds to be inserted into defects to promote 
healing and tissue replacement. Conclusion: Stem cells from dental 
tissues have a real potential in Advanced Therapies. The combination 
of inductive scaffold materials with stem cells might optimize the 
approaches for bone regeneration. Although there are numerous 
available biomaterials potentially compatible to combine with MSCs, 
more studies need to be performed, due to the fact that for each 
indication there will be a more suitable material according to the 
defect’s biological and mechanical requirement.
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Introduction
The potential therapeutic use of stem cells has 
been the focus of much research in recent years. 
The ability to restore cells and tissues function 
without the need to use immunosuppressive drugs 
and without concern for tissue compatibility makes 
mesenchymal stem cells (MSCs, usual acronym) a 
strong promise for the future. Until now, several 
progenitor cells derived from dental tissues have 
been isolated and characterized (table I).
Table I – Sources of stem-cells from dental tissues 
•	 Dental pulp stem-cells (DPSCs) [12]
•	 Stem-cells from human exfoliated deciduous 
teeth (SHED) [23]
•	 Periodontal ligament stem-cells (PDLSCs) 
[28]
•	 Precursor cells from human dental follicle 
(PCs) [25]
•	 Oral keratinocyte stem-cells [17]
•	 Mandibular bone marrow stem-cells 
(MBMSC) [18]
•	 Apical papilla stem-cells [31]
•	 Supernumerary tooth pulp stem-cells [15]
•	 Human tooth bud stem-cells [33]
•	 Human natal dental pulp stem-cells (hNDPs) 
[19]
•	 Human oral mucosa stem-cells (hOMSC) [22]
•	 Gingiva hyperplasia stem-cells [34]
Stem cells derived from dental tissue are 
isolated from specialized tissues and have a strong 
ability to give rise to other cell lines, but with a 
different potential of stem cells derived from bone 
marrow [16].
For stem cells to be used in tissue engineering a 
scaffold is essential to provide the necessary support 
for the transport of nutrients and oxygen and the 
elimination of metabolic waste [30], promoting 
an conducive environment for cell growth and 
differentiation.
The development of new biomaterials for use 
in tissue engineering provides a scientific basis for 
the creation of scaffolds that provide appropriate 
regeneration and tissue repair [14].
This study aimed to provide a literature review of 
current and future materials for use as scaffolds for 
carrying stem cells in tissue engineering, especially 
in the bone tissue regeneration.
Literature review
Stem cells are divided primarily into two 
categories: embryonic stem cells, which are found 
in the embryo and adult stem cells found in adult 
tissues. Embryonic stem cells are present only in 
the early stages of development and are able to 
generate any cell type (pluripotent). Adult stem 
cells are found in differentiated tissues and are 
able to generate specialized cell types in some 
tissues (multipotent -  MSCs). Adult stem cells 
can be isolated from many tissues in the human 
body; we may cite bone marrow, umbilical cord, 
periosteum, cancellous bone, adipose tissue, brain, 
dental pulp, pulp of deciduous teeth, the periodontal 
ligament, etc. [6].
MSCs have a clinical attractiveness because they 
are easy to expand, have the ability to differentiate 
into various types of tissues [5], and may be directed 
to become osteocytes, chondrocytes and adipocytes. 
The high regenerator potential has aroused a great 
interest of the scientific community [3], because 
of its many clinical applications in cell therapy or 
tissue engineering.
Cell therapy is defined as the therapy that aims 
to put a population of cells directly into the injured 
area or systemically, to promote local repair or 
restore systemic health. Tissue engineering is the 
science that combines the principles of biology and 
engineering techniques in order to obtain biological 
substitutes for regenerating, replacing, modifying, 
repairing or restoring the function of organs and 
tissues arranged three-dimensionally.
The stem cells from exfoliated deciduous teeth 
(SHEDs) have a great potential for therapeutic 
use because of its differentiation capability and 
its easy access, since the collection is performed 
at the physiological exfoliation of deciduous 
tooth. The tissues before discarded may serve 
as a basis for scientific research and clinical use 
in tissue regeneration and treatment of various 
diseases [23].
The easy access, the absence of ethical conflicts, 
and especially the potential for systemic use in 
tissue engineering and cell therapy motivate many 
researchers to better understand how these cells 
work and why they present peculiarities in relation 
to stem cells found in other sources [16].
For use in tissue engineering, it is essential 
that the cells are arranged in a matrix capable of 
facilitating the transport of nutrients and oxygen 
and the removal of metabolic waste [30]. The matrix 
will promote a conducive environment for growth 
and cell differentiation.
The scaffolds can be classified as permanent or 
resorbable. The permanent scaffolds are stable in 
vivo, while the resorbable scaffolds are reabsorbed 
in vivo, metabolized by the body.
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Cell scaffolds can be cultured in vitro to synthesize 
tissue which can be implanted at the site of injury, 
using the organism itself, where the regeneration of 
tissue or organ is induced in vivo [26].
Scaffolds can be made of various types of 
materials, but there are some considerations to 
create or determine the suitability of a scaffold 
for use in tissue engineering. According to O’Brien 
(2011) [26], these considerations are biocompatibility, 
biodegradability, mechanical properties consistent 
with the anatomical site that will receive the scaffold 
architecture that enables a cellular penetration and 
diffusion of nutrients, and the technology used to 
enable the production on a smaller scale
In situations of large tissue defects, it is 
difficult to obtain repair and natural regeneration 
using only local administration of cells because 
in these situations not only the cells, but also 
the extracellular matrix and the surrounding 
environment (anatomical contour) may have been 
lost. Thus, to induce tissue regeneration, an artificial 
environment to the cells (scaffolds) may be used 
in order to assist in cell adhesion and consequent 
proliferation and differentiation [32].
Biomaterials play an important role in tissue 
regeneration, because they will hold the space for 
tissue growth and will also facilitate the integration 
with the host [8], it is a substitute of the extracellular 
matrix. Typically, three groups of biomaterials are 
used to manufacture scaffolds: ceramic, synthetic 
polymers, and natural polymers [26] (table II).
Table II – Main characteristics of biomaterials with potential application for tissue engineering 
Material type Main characteristics
Natural 
polymers
Collagen
Low toxicity, low chronic inflammatory response, can be combined 
with other natural or synthetic materials. Its main disadvantage is 
the low mechanical strength [35].
Fibrin
Platelet-rich 
plasma
Silk
Synthetic 
polymers
PGA Can be manufactured with different times of degradation, 
mechanical properties, shape and porosity, but have low cell 
adhesion [21],  low ductility [1]  and low bioactivity [37].
PLA
PCL
Ceramics
Hydroxyapatite Biocompatible, similar to the inorganic component of bone, 
osteoconductiveness, absence of protein (providing lack of 
immune response) and high degradation time in vivo [2].  
However, they have poor mechanical properties  [27].
Tricalcium 
phosphate
The ceramics scaffolds such as hydroxyapatite 
and tricalcium phosphate, have been widely used in 
bone regeneration because of their biocompatibility, 
similarity to the inorganic component of bone, 
osteoconductiveness, absence of protein in their 
composition (providing lack of immune response) 
and because of its high degradation time in vivo 
[2], which allows bone remodeling at the site of 
grafting. Its disadvantages are its low structural 
stiffness (and may not be used in large mechanical 
stresses regions) and its porous nature, which 
increases the risk of fractures [36]. They are quite 
used in orthopedics and dentistry to repair bone 
defects, maintenance of the alveolar ridge as well 
as orthopedic and dental implants [20].
Despite its advantages, the hydroxyapatite 
and tricalcium phosphate are not osteoinductive 
materials; hydroxyapatite is resorbed more slowly 
than the tricalcium phosphate, and their mechanical 
properties are poor, resulting in the inability to use 
on large bone defects which require stabilization [27]. 
In such cases synthetic and natural polymers may 
be used to overcome these limitations. The most 
studied synthetic polymers for bone reconstruction 
include: polyglycolic acid (PGA), polylactic acid 
(PLA), and polycaprolactone (PCL) [2].
Natural biomaterials used in scaffolds may be 
made from components found in the extracellular 
matrix, such as collagen, fibrinogen, hyaluronic 
acid, etc., thus having the advantage of being 
biocompatible, and having mechanical properties 
similar to natural tissue [7].
The advantages of natural polymers include low 
toxicity and low chronic inflammatory response, in 
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addition to the possibility of being combined with 
other natural or synthetic materials [35]. These 
materials also provides a good environment for 
stem cell culture [7]. Its disadvantages include low 
mechanical strength, difficult to handle and need 
for chemical modification [35].
Among the natural polymers, we can mention 
the platelet-rich plasma (PRP) and platelet-rich 
fibrin (PRF). The platelet concentrates are widely 
used in tissue regeneration because of its high 
content of growth factors and their easy processing 
[9]. The combined use of stem cells and platelet 
concentrates causes that the factors secreted by 
concentrated enrich the culture medium, enhancing 
tissue regeneration capacity [24], but it has low 
stability for regenerative medicine [29].
Each tissue requires specific requirements 
resulting from the type of tissue cell site, function, 
and mechanical properties. For bone remodeling, it 
is necessary that the scaffold material has a porosity 
and also can be produced in a three-dimensional 
anatomic shape [35]. Best results were obtained 
with the combination of MSCs and porous ceramics, 
in which the properties of ceramics have been 
integrated with the properties of the osteoprogenitor 
cells to form a vital and vascularized bone tissue, 
with biomechanical properties [4].
The success of osteoinductive grafts depends 
on the efficiency of the scaffold material. The ideal 
scaffold should increase the exposure of the host 
tissue to the growth substance and ensure uniform 
distribution. It should be safe, biocompatible, 
biodegradable, and resorbable as will occur bone 
formation [13].
Discussion
Stem cells are undifferentiated cells capable 
of unlimited self-renewal and to differentiate into 
several cell types. Stem cells show great therapeutic 
potential, is promising in tissue repair area in order to 
regenerate and restore the normal function [10].
The large potential capacity for differentiation 
of the MSCs, the possibi l it y of g ra f t ,  the 
immunosuppressive effects, and expansion in 
culture led to increased clinical interest in the 
use of these cells via intravenous infusion or 
site-directed administration in many situations 
pathological [4].
The design of the scaffold is critical since 
it must be capable of supporting cell adhesion 
and proliferation, and have favorable mechanical 
properties. In addition, there are parameters 
that must be considered for building a scaffold, 
including porosity, mechanical integrity, and effect 
of the surface morphology in cell adhesion and 
proliferation [38].
Currently, the autogenous bone graft has 
been used as the gold standard for repair and 
bone replacement. However, the use of this type 
of graft has several disadvantages, including 
cost, the trauma, the possibility of donor site 
morbidity, limited availability, and resorption. 
These disadvantages can be eliminated by the use 
of allografts, which are obtained from living donors 
or tissue banks. Despite increased availability and 
donor site morbidity disposal, this type of graft 
is associated with the transmission of diseases, 
bacterial infection, and immune rejection, in 
addition to presenting a limited osteoconductiveness 
[11]. Thus, the creation of the ideal material for 
bone replacement is necessary [20].
The selection of the biomaterial to be used 
in the scaffold is also of extreme importance; in 
addition to being biocompatible, promote chemical 
stability, having good physical properties, have 
a controlled degradation, allowing cell adhesion 
and proliferation, the biomaterial should mimic 
completely or partially the extracellular matrix of 
the tissue that will be replaced [38].
One of the major advantages of t issue 
engineering is the possibility of creating tissue 
so that they correspond exactly to the individual 
requirements such as size, shape, and immunological 
compatibility while minimizing the need for further 
treatment [35].
Conclusion
Stem cells point to a promising future in 
dentistry to replicate dental tissues, in order to 
repair or recover them, especially in endodontics, 
periodontics and surgery (grafting).
The use of biomateria ls in bone t issue 
engineering has many advantages over traditional 
surgical procedures. The possibility of using 
biomaterials to repair large bone defects replace 
the need for traditional surgery grafting, giving a 
new chance for bone repair. Among the scaffolds, 
ceramics receive a lot of attention when you want 
to restore the bone tissue, especially hydroxyapatite 
and tricalcium phosphate. 
Although studies with stem cells are at an early 
stage, they have a great therapeutic potential. It is 
expected that in future the isolation of stem cells 
from various parts of the human body would be 
possible, and, along with appropriate scaffolds, 
MSCs could be applied for the treatment of numerous 
disorders in dentistry and medicine.
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